Improving surveillance for Barrett's oesophagus: Better to be looked over than be overlooked

doi:10.1136/bmj.332.7556.1511-c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Shaji Sebastian, consultant gastroenterologist (shaji.sebastian@hey.nhs.uk),
Colm O'Morain, head

Hull Royal Infirmary, Hull HU3 2JZ
Department of Gastroenterology, Adelaide and Meath Hospital, Dublin 24, Republic of Ireland

EDITOR—The audit by Bampton et al highlights the practical problems encountered in the area of Barrett's oesophagus surveillance.1 Our retrospective audit of 441 patients with Barrett's oesophagus in a university teaching hospital setting showed an alarmingly low compliance rate of 8.6%.2 The main area of concern was that quadrantic biopsies were not taken in a large proportion of …